Biodexa Pharmaceuticals Plc (BDRX)
1.245
-0.08
(-5.68%)
USD |
NASDAQ |
May 02, 16:00
1.22
-0.02
(-2.01%)
After-Hours: 04:45
Biodexa Pharmaceuticals Enterprise Value: -2.147M for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | -2.147M |
| May 01, 2024 | -1.818M |
| April 30, 2024 | -0.9851M |
| April 29, 2024 | -1.862M |
| April 26, 2024 | -1.906M |
| April 25, 2024 | -4.428M |
| April 24, 2024 | -4.318M |
| April 23, 2024 | -4.063M |
| April 22, 2024 | -4.252M |
| April 19, 2024 | -4.309M |
| April 18, 2024 | -4.010M |
| April 17, 2024 | -3.877M |
| April 16, 2024 | -3.833M |
| April 15, 2024 | -3.993M |
| April 12, 2024 | -3.585M |
| April 11, 2024 | -3.389M |
| April 10, 2024 | -3.351M |
| April 09, 2024 | -3.265M |
| April 08, 2024 | -3.090M |
| April 05, 2024 | -2.914M |
| April 04, 2024 | -2.520M |
| April 03, 2024 | -2.783M |
| April 02, 2024 | -1.643M |
| April 01, 2024 | -1.204M |
| March 28, 2024 | -0.7223M |
| Date | Value |
|---|---|
| March 27, 2024 | -3.956M |
| March 26, 2024 | -4.201M |
| March 25, 2024 | -3.442M |
| March 22, 2024 | -3.144M |
| March 21, 2024 | -3.104M |
| March 20, 2024 | -3.144M |
| March 19, 2024 | -3.229M |
| March 18, 2024 | -2.762M |
| March 15, 2024 | -2.634M |
| March 14, 2024 | -2.804M |
| March 13, 2024 | -2.210M |
| March 12, 2024 | -2.210M |
| March 11, 2024 | -2.040M |
| March 08, 2024 | -2.082M |
| March 07, 2024 | -2.040M |
| March 06, 2024 | -2.125M |
| March 05, 2024 | -2.167M |
| March 04, 2024 | -2.082M |
| March 01, 2024 | -1.827M |
| February 29, 2024 | -3.830M |
| February 28, 2024 | -3.681M |
| February 27, 2024 | -3.502M |
| February 26, 2024 | -3.473M |
| February 23, 2024 | -3.175M |
| February 22, 2024 | -3.027M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-4.974M
Minimum
Nov 09 2023
41.77M
Maximum
May 08 2019
9.332M
Average
6.008M
Median
Feb 08 2022
Enterprise Value Benchmarks
| Adaptimmune Therapeutics PLC | 146.78M |
| NuCana PLC | -13.56M |
| Autolus Therapeutics PLC | 853.39M |
| Mereo BioPharma Group PLC | 383.22M |
| Bicycle Therapeutics PLC | 439.54M |
Enterprise Value Related Metrics
| Earnings Yield | -32.29K% |
| Normalized Earnings Yield | -35188.55 |